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We herein report a case of primary living-donor liver transplantation (LDLT) for delayed diagnosis of
biliary atresia under percutaneous transhepatic cholangio-drainage (PTCD). The case was a 10 months
old female infant who was born in other Asian country and had been treated for cytomegalovirus
hepatitis. After she moved to Japan at 9 months of age, she visited the referring hospital because of high
fever. Severe jaundice and liver dysfunction were detected, and she was transferred to our hospital.
Because of intrahepatic bile duct dilatation detected by computed tomography (CT), a PTCD tube was
inserted to reduce jaundice, and liver biopsy was performed under general anesthesia. CT and pathologic
ﬁndings led to the diagnosis of biliary atresia with liver cirrhosis. The patient was scheduled to undergo
primary LDLT without Kasai portoenterostomy because of the progression of irreversible liver cirrhosis.
While waiting for improvement of the severe fatty liver in her mother, a candidate donor, she underwent
bile juice re-administration via the nasogastric tube. During this period, the total bilirubin did not in-
crease above that at admission, and the albumin gradually improved. She underwent LDLT at 15 months
of age, and her postoperative course was uneventful.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license. Rhu et al. [1] reported that a >60-day delayed diagnosis of
biliary atresia (BA) is a potential risk for a bad prognosis involving
the native liver. Chardot et al. [2] also reported that performance of
Kasai portoenterostomy (PE) after 3 months of age is justiﬁed in
only select patients without advanced liver disease for whom liver
transplantation should not be delayed. Thus, in general, in
extremely late-diagnosed patients, primary living-donor liver
transplantation (LDLT) can be considered if the liver is already
cirrhotic [3].
Some reports concluded that donors with severe fatty liver are
not good liver donor candidates because of high complication rates
[4e6]. Recently, Oshita et al. [7] reported that the use of diet-treated
donors with steatotic livers for LDLT is feasible with respect to
donor safety and recipient outcome.
We herein report the ﬁrst case of successful primary LDLT
without Kasai PE at the age of 15 months after percutaneous
transhepatic cholangio-drainage (PTCD). In this case, the patient’s
age at diagnosis for BA with cirrhosis was 9 months. While the
donor’s fatty liver was being improved by dietary therapy,5; fax: þ81 59 232 6968.
Koike).
-NC-ND license. successful management of the patient’s nutritional status by re-
administration of bile juice and vaccination were performed.
1. Case report
A 10-month-old female infant was admitted to our hospital with
jaundice and liver dysfunction. She was born in another Asian
country and had been treated for cytomegalovirus (CMV) hepatitis.
After she moved to Japan at 9 months of age, she visited the
referring hospital because of a high fever. Severe jaundice and liver
dysfunctionwere found, and she was transferred to our hospital for
further examination and treatment.
At admission to our hospital, her vital signs were within their
normal ranges with a low-grade fever. On physical examination,
she had a slightly greenish face and mild hepatosplenomegaly.
Defecation was normal, but her stool was always cream- or white-
colored with negative fecal bilirubin. Laboratory data showed se-
vere jaundice, markedly elevated liver transaminase [total bilirubin,
8.9 mg/dL; aspartate aminotransferase (AST), 163 IU/L; alanine
aminotransferase (ALT), 85 IU/L], and malnutrition (albumin, 2.3 g/
dL; cholinesterase, 69 IU/L). Coagulation times were slightly pro-
longed (activated partial thromboplastin time, 56.6 s; prothrombin
time, 14.8 s). A CMV test showed a past infectious pattern [CMV
Fig. 1. (A) Cholangiography using the percutaneous transhepatic cholangio-drainage (PTCD) tube showed complete bile duct obstruction at the hepatic portal lesion. (B) Computed
tomography (CT) revealed dilatation of the intrahepatic bile duct and no evidence of a space-occupying lesion at the hepatoduodenal ligament. (C) The pathological ﬁndings of the
liver biopsy at admission revealed progression of hepatic ﬁbrosis and cirrhotic changes. (D) Intraoperative cholangiography through the gallbladder at the age of 15 months showed
type 3 BA.
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positive]. Because of intrahepatic bile duct dilatation detected by
computed tomography (CT), PTCD tube insertion was planned to
reduce jaundice. After verbal and written informed consent was
obtained from her parents and safe levels of both coagulation pa-
rameters and platelet counts were conﬁrmed, PTCD drainage and
liver biopsy were performed under general anesthesia. The labo-
ratory ﬁndings and pathologic ﬁndings, including complete bile
duct obstruction at the hepatic portal lesion as revealed by chol-
angiography (Fig. 1A), no evidence of a space-occupying lesion at
the hepatoduodenal ligament on CT (Fig. 1B), and progression of
hepatic ﬁbrosis, led to the diagnosis of BA with liver cirrhosis
(Fig. 1C).
She was scheduled to undergo primary LDLT without Kasai PE
because of the progression of irreversible liver cirrhosis and under
the consideration that there are insufﬁcient brain-dead donors in
Japan. Oral and written informed consent was obtained from her
parents.
However, her mother, whowas the only candidate liver donor in
her family, was notmatched because of severe fatty liver at the time
of PTCD tube insertion. We proposed to the patient’s family that her
mother would try to improve her fatty liver by dietary and exercise
therapy for a while. The patient had been undergoing bile juice
re-administration from the PTCD using a nasogastric tube prior to
the LDLT.
The time course of laboratory data from admission to LDLT is
shown in Fig. 2. The mother’s fatty liver improved as a result of
dietary and exercise therapy for half a year. The total bilirubin did
not increase above that at admission, and the albumin gradually
improved. There was no worsening in the total bilirubin level, Pe-
diatric End-Stage Liver Disease (PELD score), or prothrombin time-international normalized ratio (PT-INR) during this period. She had
also undergone vaccination during this period, including that
against mumps, measles, varicella, hemophilus inﬂuenza, and
pneumococcus. The patient underwent LDLT at the age of 15
months. Intraoperative cholangiography through the gallbladder
revealed type 3 BA (Fig. 1D). The pathological ﬁndings of the
resected liver, namely the progression of hepatic ﬁbrosis, were
similar to those of the previous liver biopsy at 6 months before
LDLT.
After LDLT, her jaundice was dramatically improved with no
evident rejection of the liver allograft. Postoperative graft function
was excellent, and no major complications occurred.
2. Discussion
There are three potential advantages of PTCD tube insertion for
delayed diagnosis of BAwith irreversible cirrhosis, as in the present
case. First, in the present case, judging from the pathological ﬁnd-
ings of the liver at the time of PTCD insertion and at LDLT, PTCD tube
insertion had a possible suppressive effect on the progression of
liver cirrhosis. This suppressive effect provided her with a window
of opportunity for vaccination before performing LDLT. Moreover,
although Japan is lacking in brain-dead donors, this additional time
allowed her mother (donor) to improve her fatty liver before
transplantation. Second, after insertion of the PTCD tube, the pa-
tient’s nutritional status was improved step by step with the re-
administration of bile juice via the nasogastric tube. Her albumin
level had been elevated and maintained at >3.0 g/dL from 1 month
after the PTCD insertion. Some authors have reported that nutri-
tional support has a beneﬁcial effect on preventing perioperative
infections associated with liver transplantation [8,9]. In this case,
Fig. 2. Time course of changes in laboratory data from admission to living-donor liver transplantation (LDLT), including total bilirubin level, Pediatric End-Stage Liver Disease (PELD)
score, albumin level, and prothrombin time-international normalized ratio (PT-INR). After insertion of the percutaneous transhepatic cholangio-drainage (PTCD) tube and re-
administration of bile juice, her albumin level was dramatically improved and maintained at >3.0 g/dL from 1 month after the PTCD insertion to the LDLT period. There was no
worsening in the PELD score, total bilirubin level, or PT-INR during this period.
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complications. Third, in this case, primary LDLT without Kasai PE
has the advantage of no surgery-related intra-abdominal adhesion
operation compared with LDLT after Kasai PE. Sandler et al. [10]
reported that liver transplantation following Kasai PE was associ-
ated with a higher blood transfusion volume at the time of the
operation and a higher rate of postoperative bowel perforation
compared with liver transplantation without Kasai PE. Sugawara
et al. also reported that if the number of previous PEs was twice or
more before the LDLT for BA, the operation time tended to be
longer, the volume of blood loss tended to be greater, and vascular
complications tended to be more frequent because of severe intra-
abdominal adhesions at the time of LDLT [11].
3. Conclusion
Based on these results and those of a similar case (concomitant
with intrahepatic bile duct dilatation in BA), PTCD insertionwithout
PE during the waiting period for LDLT might be an acceptable
therapeutic option because of the above-described advantages,
especially in countries such as Japan, inwhich the ability to perform
a liver transplantation with a brain-dead donor is lacking.
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